[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fG4UKrBQllfaYayFYkkC71vATiWAtwjZR5a5IT9mZKj4":8,"$fxQid1vqtq4F2RhtAme_y_VQNNkndxgAS-XvjbMYNF9s":55,"$fXa0ajIpCbtfKGRSu6AyOgNPkCSkODHhups0ao88fWXs":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75484,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"乳腺癌分期1药物治疗用药要点全解","","https://ystcdn.venuertc.com/venue/AI/f9923ef0-ebbc-4fa1-b701-58913c2421c5.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">乳腺癌分期1药物治疗用药要点全解\u003C/h1>\n  \u003Cdiv class=\"material-section material-section-bg01\">\n    \u003Ch2 class=\"material-subtitle\">化疗及辅助药物简介\u003C/h2>\n    \u003Cp>说起来化疗和靶向药，很多朋友都觉得神秘。其实，它们就是治疗中用来控制肿块、抑制异常细胞增殖的专用药物，包括吡柔比星、环磷酰胺、紫杉醇脂质体等。辅助药物如地塞米松、苯海拉明，则是为了减少化疗时带来的不适。今天这篇指南，将带你快速掌握分期1治疗常用药物的\u003Cstrong>7大用药关键\u003C/strong>，助你安全用药无忧。\u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg02\">\n    \u003Ch2 class=\"material-subtitle\">01 ⏰ 服药时间与给药方法明确区分\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\u003Cspan class=\"material-point-title\">1）吡柔比星、环磷酰胺、紫杉醇脂质体的用法\u003C/span>\n        \u003Cbr>这三种常用化疗药都需要\u003Cstrong>静脉输注\u003C/strong>，不口服，需在医院有经验的人员操作。每种药物都有明确的给药周期（如紫杉醇脂质体常用每3周/21天一疗程），一定不能随意提前或推迟。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">2）辅助药物的使用时机\u003C/span>\n        \u003Cbr>苯海拉明、地塞米松通常需要\u003Cstrong>提前在化疗给药前注射\u003C/strong>，以预防过敏和减少不适反应。西咪替丁主要用于胃部保护，多在化疗期间同步输注或口服。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">3）正确做法：\u003C/span>\n        \u003Cbr>严格按照医嘱和护士指导的时间、顺序用药。不要自行改动疗程，也避免遗漏任何一道预处理或辅助药品。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg03\">\n    \u003Ch2 class=\"material-subtitle\">02 💊 剂型与用药技巧详解\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\u003Cspan class=\"material-point-title\">1）化疗主要剂型\u003C/span>\n        \u003Cbr>吡柔比星、环磷酰胺、紫杉醇脂质体均以\u003Cstrong>注射剂\u003C/strong>形式使用。这些药物没有片剂、胶囊等口服形式，家中无法自己操作使用。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">2）苯海拉明、地塞米松剂型\u003C/span>\n        \u003Cbr>临床用于防护副作用时，多以注射剂给药。部分场景可用口服片剂，但需医生明确指示。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">3）特殊技巧：\u003C/span>\n        \u003Cbr>静脉输注期间，如发现针口肿痛或药液渗漏，需立刻告诉医护人员。不要擅自按压、涂药，以免影响局部。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg04\">\n    \u003Ch2 class=\"material-subtitle\">03 ⚠️ 药物相互作用要警惕\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\u003Cspan class=\"material-point-title\">1）主要化疗药的相互作用\u003C/span>\n        \u003Cbr>吡柔比星、环磷酰胺、紫杉醇脂质体与某些抗生素（如万古霉素）、抗癫痫药、部分降压药同用时，毒副作用或疗效会受到影响。说明书建议：\u003Cstrong>如需联合用药，必须提前告知医生与药师\u003C/strong>。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">2）辅助药物与其他用药\u003C/span>\n        \u003Cbr>地塞米松与部分抗凝药物（华法林）同时用，会加重胃肠不适。西咪替丁可与某些抗癫痫药、中枢药发生代谢竞争，需小心调整。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">3）正确做法：\u003C/span>\n        \u003Cbr>用药期间，如果必须长期服某些慢性病药，\u003Cstrong>建议携带所有用药清单\u003C/strong>，让医生、药师调整计划，避免药物叠加风险。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg05\">\n    \u003Ch2 class=\"material-subtitle\">04 👵 特殊人群用药调整要点\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">1）老年患者\u003C/span>\n        \u003Cbr>化疗药在代谢及排泄上受肾功能、肝功能影响较大。对于65岁以上人群，起始剂量通常需下调，避免毒性反应累积。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">2）肝/肾功能减退者\u003C/span>\n        \u003Cbr>紫杉醇类和吡柔比星特别依赖肝脏代谢，建议肝酶异常者遵循个体化剂量调整。肾功能不全时，环磷酰胺需适当减量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">3）孕妇与哺乳期妇女\u003C/span>\n        \u003Cbr>说明书明确：\u003Cstrong>禁用\u003C/strong>（FDA D或X类）！有生育计划者用药前务必与医生充分沟通。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">4）儿童及青少年\u003C/span>\n        \u003Cbr>本组药物不推荐儿童及青少年常规使用，特殊情况按专科医师指导严格计算剂量。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">用药小案例：\u003C/span>\u003Cbr>一位61岁女性使用紫杉醇脂质体化疗，未出现肝肾异常，经调整间隔周期后副作用明显控制，显示个体剂量调整的重要性。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg06\">\n    \u003Ch2 class=\"material-subtitle\">05 🚩 常见不良反应与应对\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\u003Cspan class=\"material-point-title\">1）吡柔比星、环磷酰胺\u003C/span>\n        \u003Cbr>常见一时性骨髓抑制（如白细胞下降）、注射部位轻度红肿。部分人偶有脱发、皮肤色素沉着。\n        \u003Cbr>如果感觉浑身乏力、发热，及时沟通医护，必要时做相关血液检查。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">2）紫杉醇脂质体\u003C/span>\n        \u003Cbr>临床数据显示，约20-30%患者会出现短暂麻木感或轻度关节酸痛，极少数人有过敏反应。使用期间若感到眼皮、面部肿胀或者皮疹，应立刻停药。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">3）苯海拉明、地塞米松\u003C/span>\n        \u003Cbr>有可能引起短暂嗜睡、口干。地塞米松如大剂量反复用，可能诱发胃肠道不适或短暂血糖升高。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">4）出现严重反应的处理方法：\u003C/span>\n        \u003Cbr>任何呼吸急促、全身过敏、持续高烧等异常，建议立刻就医并报告药品名称与用法。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material-data-point\">临床资料显示，紫杉醇脂质体出现神经不良反应的发生率小于30%（Gradishar et al., 2005），大多数可通过调整剂量安全处理。\u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg07\">\n    \u003Ch2 class=\"material-subtitle\">06 🏠 储存条件与有效期\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\u003Cspan class=\"material-point-title\">1）化疗药品储存\u003C/span>\n        \u003Cbr>吡柔比星、环磷酰胺及紫杉醇脂质体均需在2-8℃避光冷藏。药品不得反复解冻，避免长期暴露于室温。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">2）辅助药物储存\u003C/span>\n        \u003Cbr>注射用苯海拉明、地塞米松多为常温保存，干燥避光。开封后请在24小时内用完，剩余药液不得重复使用。\n      \u003C/li>\n      \u003Cli>\u003Cspan class=\"material-point-title\">3）过期和变质药品的处理\u003C/span>\n        \u003Cbr>不得丢入生活垃圾或下水道，建议\u003Ca href=\"https://www.fda.gov/consumers/consumer-updates/where-and-how-dispose-unused-medicines\" target=\"_blank\" class=\"material-link\">按药品回收规定处理\u003C/a>。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material-data-point\">《中国医院药品管理规范》建议，所有注射剂应实施定期效期检查，过期药禁止误用。\u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg08\">\n    \u003Ch2 class=\"material-subtitle\">07 ❗ 漏服与过量的应急处理\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">1）静脉注射类药物\u003C/span>\n        \u003Cbr>如因特殊原因遗漏化疗（如紫杉醇脂质体），请联系主管医生，由其重新安排行程，\u003Cstrong>严禁自行补用\u003C/strong>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">2）辅助口服药漏服\u003C/span>\n        \u003Cbr>如地塞米松片漏服，第一时间补服即可，但不建议连服两倍剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">3）一旦过量用药\u003C/span>\n        \u003Cbr>出现明显不适或剂量过大，需尽快至医疗机构，由专业人员进行观察和救治。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material-data-point\">提醒：注射剂类药物绝不允许自行处理过量问题，出现疑似中毒或严重反应，应当立即送医。\u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-bg09\">\n    \u003Ch2 class=\"material-subtitle\">08 📋 出院后药物管理与复查\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">1）按时完成所有辅助用药\u003C/span>\n        \u003Cbr>如医嘱中有地塞米松/西咪替丁等维持方案，离院后务必按指示足量服完，无需主动停止。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">2）妥善保存所有用药信息\u003C/span>\n        \u003Cbr>建议随身携带详尽用药表，并做好药物购买和使用的批次记录。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"material-point-title\">3）定期医学随访\u003C/span>\n        \u003Cbr>全部静脉用药需定期复查血象、肝肾功能，并及时向医生反馈可能的不良反应。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"material-data-point\">实际用药案例提示，坚持规范复查和按时用药，有助于显著降低化疗药副作用发生率。\u003C/p>\n  \u003C/div>\n  \u003Cdiv class=\"material-section material-section-summary\">\n    \u003Ch2 class=\"material-subtitle\">总结\u003C/h2>\n    \u003Cp>分期1常用化疗与辅助药品，有各自的用法和注意事项。\u003Cstrong>严格按医嘱输注\u003C/strong>、规避药物相互作用、做好储存与漏服管理，是整个治疗周期中必须遵守的安全底线。个人的具体方案可能因体质、年龄、肝肾情况而调整，遇到漏服、过量或任何不适，应当及时求助专业医生。只有科学、细致的管理，才能保证化疗药物的安全与疗效。\u003C/p>\n    \u003Cp class=\"material-final-tip\">最后强调：安全用药请始终以专业指导为准，有疑问随时找药师和医生！\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-ref\">\n    \u003Ch3 class=\"material-ref-title\">参考文献\u003C/h3>\n    \u003Col>\n      \u003Cli>Gradishar, W. J., et al. (2005). Albumin-bound paclitaxel versus polyethylated castor oil–based paclitaxel in women with breast cancer. *Journal of Clinical Oncology, 23*(31), 7794-7803. https://doi.org/10.1200/JCO.2005.10.449\u003C/li>\n      \u003Cli>National Comprehensive Cancer Network (NCCN). (2024). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 2.2024. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf\u003C/li>\n      \u003Cli>FDA. (2023). Paclitaxel albumin-stabilized nanoparticle for injectable suspension (Abraxane) [package insert]. Silver Spring, MD: U.S. Food and Drug Administration. https://www.accessdata.fda.gov\u003C/li>\n      \u003Cli>Chinese Medical Association. (2022). Hospital Pharmacy Administration Guidelines [in Chinese].\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  background-color: #fafcff;\n  padding: 32px 10% 40px 10%;\n  max-width: 980px;\n  margin: 30px auto 50px auto;\n  font-family: '微软雅黑', 'Arial', sans-serif;\n  color: #222;\n  font-size: 16px;\n  line-height: 1.82;\n  border-radius: 12px;\n  box-shadow: 0 0 18px 2px #f0f0f3;\n}\n.material-title {\n  font-size: 2.1em;\n  font-weight: bold;\n  color: #2673b8;\n  text-align: center;\n  margin-bottom: 36px;\n  letter-spacing:1px;\n}\n.material-subtitle {\n  font-size: 1.35em;\n  color: #416d99;\n  margin: 0 0 16px 0;\n  padding: 18px 15px 8px 24px;\n  border-left: 8px solid #b1d3ec;\n  border-radius: 12px 0 0 12px;\n  background: linear-gradient(90deg, #e0edfa 60%, #fafdff);\n  font-weight: 700;\n  box-shadow: 0 3px 10px 0 #f6f9fd inset;\n  position:relative;\n  letter-spacing: 0.5px;\n}\n.material-section {\n  margin-bottom: 32px;\n}\n.material-section-summary {\n  background-color: #ecefff;\n  padding: 22px 22px 14px 30px;\n  border-radius: 8px;\n  box-shadow: 0 2px 8px #f3f5ff inset;\n}\n.material-list {\n  margin-left: 22px;\n  margin-bottom:12px;\n}\n.material-list li {\n  margin-bottom: 14px;\n  padding-left: 0.5em;\n  text-indent: -1.1em;\n}\n.material-point-title {\n  color: #235278;\n  font-weight: 600;\n  padding-right: 4px;\n}\n.material-data-point {\n  color: #7893b5;\n  font-size: 0.96em;\n  margin: 0.2em 0 0.5em 20px;\n  padding-left: 1em;\n  font-style: italic;\n}\n.material-final-tip {\n  background: #e4f5ee;\n  color: #316f55;\n  padding: 8px 20px 10px 20px;\n  font-size:1.08em;\n  border-radius: 6px;\n  margin-top: 22px;\n  box-shadow: 0 3px 10px #eefbee inset;\n  font-weight: 600;\n}\n.material-ref-title {\n  color: #165991;\n  font-size: 1.18em;\n  margin-bottom: 10px;\n  border-left: 6px solid #93b7df;\n  padding-left: 11px;\n}\n.material-section-ref {\n  background: linear-gradient(88deg, #e6edf8 41%, #fafdff 100%);\n  border-radius: 8px;\n  margin-top: 30px;\n  padding: 20px 30px 22px 38px;\n  font-size: 0.99em;\n}\n/* 章节背景图-淡雅渐变强化 */\n.material-section-bg01 { background: linear-gradient(97deg, #eef6fb 80%, #fff 100%); border-radius: 12px; }\n.material-section-bg02 { background: linear-gradient(86deg, #f3f7fd 77%, #fff 100%); border-radius: 12px; }\n.material-section-bg03 { background: linear-gradient(93deg, #eaf9ff 80%, #fcfbff 100%); border-radius: 12px; }\n.material-section-bg04 { background: linear-gradient(89deg, #ebf8e4 80%, #fafcf9 100%); border-radius: 12px; }\n.material-section-bg05 { background: linear-gradient(92deg, #fdf7f2 90%, #fafdff 100%); border-radius: 12px; }\n.material-section-bg06 { background: linear-gradient(95deg, #e4f2f5 77%, #fafdff 100%); border-radius: 12px; }\n.material-section-bg07 { background: linear-gradient(89deg, #f9eefa 88%, #fafdff 100%); border-radius: 12px; }\n.material-section-bg08 { background: linear-gradient(96deg, #fcf6ea 80%, #fafdff 100%); border-radius: 12px; }\n.material-section-bg09 { background: linear-gradient(94deg, #f6fafd 83%, #fcfbff 100%); border-radius: 12px; }\n.material-link {\n  color:#2b74b1;\n  text-decoration: underline;\n}\n@media (max-width:900px) {\n  .material-container {\n    padding: 26px 5% 26px 5%;\n    font-size: 15px;\n  }\n  .material-section-ref{padding:12px 13px 14px 16px;}\n}\n@media (max-width:600px) {\n  .material-container {padding: 12px 0 20px 0; font-size: 14.1px;}\n  .material-title {font-size:1.23em;}\n  .material-section-ref{font-size:0.94em;}\n}\n\u003C/style>","\u003Cdiv class=\"material-container\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">乳腺癌分期1药物治疗用药要点全解\u003C/",455,"2025-12-06 00:13:32","乳腺癌, 化疗, 药物治疗, 用药安全, 辅助药物, 不良反应, 老年患者, 药物相互作用","掌握乳腺癌分期1的化疗药物和辅助用药要点，实现安全用药。了解用药时机、剂型及不良反应，确保治疗效果最大化。","2025-12-15 15:10:35",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]